Lanean...
Survival Benefit of Combination Chemotherapy in Elderly Patients with Metastatic Pancreatic Ductal Adenocarcinoma
OBJECTIVES: Survival benefit of combination over single-agent chemotherapy for metastatic pancreatic ductal adenocarcinoma (PDAC) was demonstrated in younger patients in clinical trials. We aimed to evaluate whether this survival benefit of combination chemotherapy is present in elderly patients wit...
Gorde:
| Argitaratua izan da: | Am J Clin Oncol |
|---|---|
| Egile Nagusiak: | , , , , , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2020
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7395872/ https://ncbi.nlm.nih.gov/pubmed/32349022 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/COC.0000000000000708 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|